Announced Mon, 29 Jun · 19:46 IST
Board approves variation in use of IPO proceeds, seeks shareholder approval
Results View source PDF
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.3%1-day move
₹1326.90
prior close
₹1329.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.2+0.4-0.4-1.3+0.6+4.7+1.9+2.8+6.9+6.0———
Up moveDown movePending
AI summary
Senores Pharmaceuticals board, on June 29, 2026, approved a proposed change in the use of about Rs 1,000.16 million of unutilised IPO proceeds, out of total primary IPO proceeds of Rs 5,000 million. The change requires shareholder approval via postal ballot. The board meeting ran from 4:15 PM to 5:00 PM IST.
Likely market impact
Shareholders will vote on reallocating about 20% of IPO funds; outcome could affect growth plans and investor sentiment.